Disclosed herein are novel compositions and methods for treating or preventing upper GI tract disorders. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising at least one bile acid sequestrant in combination with one or more agents chosen from, ³-aminobutyricacid-b (GABA-B) agonists and prodrugs of GABA-B agonists.
